Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Published:2012-05-17 Issue:5 Volume:7 Page:e37229
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Ming,Zhang Qian,Fu Peifang,Li Ping,Peng Aimei,Zhang Guoliang,Song Xiaolian,Tan Min,Li Xuan,Liu Yang,Wu Yueping,Fan Suyun,Wang Changhui

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.;R Siegel;CA Cancer J Clin,2011

2. Chemotherapy for advanced non-small-cell lung cancer.;J Walling;Respir Med,1994

3. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.;R Govindan;J Clin Oncol,2006

4. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.;JH Schiller;N Engl J Med,2002

5. Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA).;C Shih;Adv Enzyme Regul,1998

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Cancer;Side Effects of Cancer Therapy;2024

2. Research Progress on the Mechanism of Occurrence and Treatment of Leptomeningeal Metastasis of Malignant Tumors;Advances in Clinical Medicine;2024

3. CCL2 promotes metastasis and epithelial–mesenchymal transition of non‐small cell lung cancer via PI3K/Akt/mTOR and autophagy pathways;Cell Proliferation;2023-10-18

4. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability;International Journal of Molecular Sciences;2023-07-25

5. A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show 18F-Fluorothymidine “Flare” on Positron Emission Tomography;Cancers;2023-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3